Illumina
Trade Illumina 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About ILMN
Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through the Core Illumina segment, which serves customers in the research, clinical and applied markets fields, and enables the adoption of a variety of genomic solutions.
ILMN Key Statistics
ILMN News
Piper Sandler analyst David Westenberg lowered the firm’s price target on Illumina (ILMN) to $185 from $190 following quarterly results. The firm keeps an Overw...
Illumina ( ) First Quarter 2025 Results Key Financial Results Revenue: US$1.04b (down 3.3% from 1Q 2024). Net income: US$131.0m (up from US$126.0m loss in 1Q...
Investors in Illumina, Inc. ( ) had a good week, as its shares rose 4.3% to close at US$81.57 following the release of its quarterly results. It looks like a cr...
Analyst ratings
54%
of 26 ratingsMore ILMN News
Illumina, Inc. ILMN reported upbeat earnings for the first quarter, but lowered its FY25 guidance, after the closing bell on Thursday. The company posted quart...
Illumina ((ILMN)) has held its Q1 earnings call. Read on for the main highlights of the call. The recent earnings call from Illumina presented a mixed outlook,...
TD Cowen analyst Dan Brennan raised the firm’s price target on Illumina (ILMN) to $89 from $86 and keeps a Hold rating on the shares. The firm says that against...